argenx SE (ADR)
General ticker "ARGX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $38.8B (TTM average)
argenx SE (ADR) follows the US Stock Market performance with the rate: 51.2%.
Estimated limits based on current volatility of 1.0%: low 832.80$, high 850.25$
Factors to consider:
- Total employees count: 73 as of 2017
Short-term ARGX quotes
Long-term ARGX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,226.32MM | $2,190.23MM | $4,164.16MM |
| Operating Expenses | $1,651.37MM | $2,211.89MM | $3,191.70MM |
| Operating Income | $-425.05MM | $-21.65MM | $972.46MM |
| Non-Operating Income | $120.55MM | $106.83MM | $310.10MM |
| Interest Expense | $0.90MM | $2.22MM | $4.09MM |
| R&D Expense | $859.49MM | $983.42MM | $1,368.35MM |
| Income(Loss) | $-304.50MM | $85.18MM | $1,282.56MM |
| Taxes | $-9.44MM | $-747.86MM | $-13.47MM |
| Profit(Loss)* | $-165.06MM | $833.04MM | $1,296.03MM |
| Stockholders Equity | $4,097.51MM | $5,498.28MM | $7,323.09MM |
| Inventory | $310.55MM | $407.23MM | $473.53MM |
| Assets | $4,542.46MM | $6,202.52MM | $8,682.70MM |
| Operating Cash Flow | $-420.33MM | $-82.75MM | $850.49MM |
| Capital expenditure | $43.81MM | $68.30MM | $6.18MM |
| Investing Cash Flow | $308.21MM | $-717.59MM | $823.88MM |
| Financing Cash Flow | $1,336.73MM | $279.76MM | $233.73MM |
| Earnings Per Share** | $-2.89 | $13.92 | $21.14 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.